Procalcitonin- A Biomarker Must Explicate Prudently

Menka Kapil, Rateesh Sareen, Alok Verma and Gupta Gn
Additional contact information
Gupta Gn: Department of Pathology, Medical Research Institute, India

JOJ Internal Medicine, 2019, vol. 1, issue 2, 60-61

Abstract: Procalcitonin is 116 amino acid peptide that belongs to the calcitonin superfamily of peptides it is an acute-phase reactant protein made by the C cells of the thyroid gland [1]. Outside from the thyroid gland, it is also produced by lungs, kidneys, liver [2] and other tissues in increasing amounts in response to bacterial endotoxin in the bloodstream. This makes PCT a more specific biomarker for infection than acute phase reactants like erythrocyte sedimentation rate or C-reactive protein. Procalcitonin is a useful marker for the diagnosis of systemic inflammatory response that is one of the primary responses to microbial invasion [3] which leads to systemic illness which is known as sepsis. Several studies on plasma procalcitonin have demonstrated its role in the diagnosis of sepsis, prognosis of acute severe pancreatitis and even as a prognostic marker following major surgery [4,5].

Keywords: journal of orthopaedics; orthopaedics journals impact factor; orthopaedics articles impact factor; scholarly publishing orthopedics journals; juniper publishers opena ccess orthopedics journal; Rheumatology; rheumatology journals impact factor 2018; rheumatology journals impact factor; rheumatology open access journals; juniper publishers review (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/jojim/pdf/JOJIM.MS.ID.555562.pdf (application/pdf)
https://juniperpublishers.com/jojim/JOJIM.MS.ID.555562.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jjojim:v:1:y:2019:i:2:p:60-61

DOI: 10.19080/JOJIM.2019.01.555562

Access Statistics for this article

JOJ Internal Medicine is currently edited by Sophia Mathis

More articles in JOJ Internal Medicine from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().